Abstract
The antimicrobial activity of clarithromycin was compared with that of erythromycin in experimentally infected mice by whole-body autobacteriography. In mice with systemic staphylococcal infections, the number of vital microbes in the body was relatively low in the early period after oral administration of erythromycin, but increased thereafter to the levels found in nonmedicated control mice. On the other hand, with clarithromycin treatment, a significantly smaller number of microbes was evident throughout the body. The microbes were scarcely seen in the parenchyma of any organs during the examination period. This potent antimicrobial activity of clarithromycin compared with that of erythromycin was further demonstrated in mice with respiratory infections. On the other hand, to examine the distribution properties of both antibiotics in the whole body, an autoradiographic study was carried out with [N-methyl-14C]clarithromycin and [N-methyl-14C]erythromycin. Both labeled antibiotics were distributed widely throughout the body after oral administration in both uninfected control mice and mice with systemic infections. However, the radioactivity was more marked and persistent for [14C]clarithromycin than it was for [14C]erythromycin, particularly in the lungs. The observations described above indicate the superior in vivo antimicrobial activity of clarithromycin compared with that of erythromycin and suggest that the superiority of clarithromycin is largely attributed to its favorable distribution properties. The advantages of whole-body autobacteriography, coupled with whole-body autoradiography, are discussed.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonventre P. F., Imhoff J. G. The localization of Staphylococcus aureus in mice by whole-animal radioautography. Am J Pathol. 1966 Jan;48(1):149–163. [PMC free article] [PubMed] [Google Scholar]
- Bowie W. R., Shaw C. E., Chan D. G., Black W. A. In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis. Antimicrob Agents Chemother. 1987 Mar;31(3):470–472. doi: 10.1128/aac.31.3.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chin N. X., Neu N. M., Labthavikul P., Saha G., Neu H. C. Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1987 Mar;31(3):463–466. doi: 10.1128/aac.31.3.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fernandes P. B., Bailer R., Swanson R., Hanson C. W., McDonald E., Ramer N., Hardy D., Shipkowitz N., Bower R. R., Gade E. In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob Agents Chemother. 1986 Dec;30(6):865–873. doi: 10.1128/aac.30.6.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Floyd-Reising S., Hindler J. A., Young L. S. In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents. Antimicrob Agents Chemother. 1987 Apr;31(4):640–642. doi: 10.1128/aac.31.4.640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kohno S., Sasayama K., Doutsu Y., Yamashita K., Shibuya N., Miyazaki T., Koga H., Nakazato H., Nagasawa M., Suyama N. [Experimental Pseudomonas pneumonia model in normal mice]. Kansenshogaku Zasshi. 1986 Nov;60(11):1165–1171. doi: 10.11150/kansenshogakuzasshi1970.60.1165. [DOI] [PubMed] [Google Scholar]
- Kohno Y., Yoshida H., Suwa T., Suga T. Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats. Antimicrob Agents Chemother. 1989 May;33(5):751–756. doi: 10.1128/aac.33.5.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lazarevski T., Radobolja G., Djokić S. Erythromycin VI: kinetics of acid-catalyzed hydrolysis of erythromycin oxime and erythromycylamine. J Pharm Sci. 1978 Jul;67(7):1031–1033. doi: 10.1002/jps.2600670747. [DOI] [PubMed] [Google Scholar]
- Majer J., Stanaszek R. S., Mueller S. L., Marti G. N-Didemethyl-n-propionyl-6,9;9, 12-erythromycin A-spiroketal, a new metabolite of erythromycin ethyl succinate in man. Drug Metab Dispos. 1978 Nov-Dec;6(6):673–676. [PubMed] [Google Scholar]
- Morimoto S., Takahashi Y., Watanabe Y., Omura S. Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A. J Antibiot (Tokyo) 1984 Feb;37(2):187–189. doi: 10.7164/antibiotics.37.187. [DOI] [PubMed] [Google Scholar]
- Murphy P. J., Williams T. L., McMahon R. E., Marshall F. J. Metabolism of propionyl erythromycin lauryl sulfate. I. Fate of the propionyl erythromycin moiety in the rat. Drug Metab Dispos. 1975 May-Jun;3(3):155–163. [PubMed] [Google Scholar]
- Sakuma M., Awataguchi S., Sato Y. [The whole body autobacteriographic studies on the distribution of Staphylococcus aureus in mice]. Yakugaku Zasshi. 1970 Sep;90(9):1100–1106. doi: 10.1248/yakushi1947.90.9_1100. [DOI] [PubMed] [Google Scholar]
- Sakuma M., Sato Y. [A new technique for detection of microbes in the body and for chemotherapeutic evaluation of antibacterial agents: whole body bacterioautography]. Yakugaku Zasshi. 1969 Dec;89(12):1740–1741. doi: 10.1248/yakushi1947.89.12_1740. [DOI] [PubMed] [Google Scholar]
- Sakuma S., Sakuma M., Okaniwa A., Sato Y. Detection of Erysipelothrix insidiosa in mice by whole body autobacteriography. Natl Inst Anim Health Q (Tokyo) 1973 Summer;13(2):54–58. [PubMed] [Google Scholar]
- Segreti J., Kessler H. A., Kapell K. S., Trenholme G. M. In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis. Antimicrob Agents Chemother. 1987 Jan;31(1):100–101. doi: 10.1128/aac.31.1.100. [DOI] [PMC free article] [PubMed] [Google Scholar]